Disc Medicine to Participate in the Jefferies Healthcare Conference
WATERTOWN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and…
Browsing Tag
Disc Medicine Inc
Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria…
<!-- Name:DistributionId Value:8807507 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for…
Disc will obtain exclusive rights to MWTX-003 and other novel anti-TMPRSS6 antibodies in the United States, Europe and other territories excluding Greater China and certain other…